HIA
TNDM icon

Harbor Investment Advisory’s Tandem Diabetes Care TNDM Stock Holding History

Harbor Investment Advisory’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5
Closed – – 1243
2020
Q2 		$0 Buy
+5
New +$399 ﹤0.01% 1224

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Harbor Investment Advisory's TNDM Position: Q3 2020 in Review

Harbor Investment Advisory sold out of Tandem Diabetes Care (TNDM) in Q3 2020, closing a stake of 5 shares.

Harbor Investment Advisory first reported a position in TNDM in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 321 funds tracked by Wall St. Rank hold TNDM as of Q3 2020.

  • Harbor Investment Advisory reported no remaining Tandem Diabetes Care position as of Q3 2020 after selling out during the quarter.
  • Harbor Investment Advisory sold 5 Tandem Diabetes Care shares in Q3 2020.
  • Harbor Investment Advisory first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 1 quarter.
  • Harbor Investment Advisory's Tandem Diabetes Care position peaked at $0 in Q2 2020.
  • 321 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2020.

Based on Harbor Investment Advisory's 13F filing for Q3 2020, filed 23 Oct 2020.